Some investment themes keep coming back no matter what the market does from one session to the next. Spending on artificial intelligence, the need for more electric power, the steady stream of cyberattacks, the push into obesity treatment, and the shift of business software to the cloud have all shaped the market for several years. The five stocks below sit at the center of those themes, and each carries a strong buy consensus from Wall Street analysts as of October 19, 2026.
The backdrop matters. Inflation has run hotter than the Federal Reserve wants, Treasury yields remain high, and the Fed meets on October 27-28. Meta Platforms, Tesla, IBM, Lam Research, and Texas Instruments are all scheduled to report results on October 21, and those reports could move the AI and chip trade. The ideas below span semiconductors, cybersecurity, pharmaceuticals, power equipment, and e-commerce and cloud computing. Editorial notes only, not investment advice.
NVIDIA (NVDA) – The Core Supplier of AI Computing
NVIDIA designs the graphics processors and networking gear that power most large AI models. Its chips are used to train and run AI systems at major cloud providers, large tech companies, and a growing number of governments. The company also sells a software platform that developers use to build on its hardware, which makes its products harder to replace. In our view, that mix of hardware and software is the main reason NVIDIA has stayed ahead of rivals.
Analyst consensus on NVIDIA reads strong buy, with the large majority of covering firms rating the stock bullish. Rosenblatt's Kevin Cassidy reiterated his Buy rating on September 29.
Risks: The stock can swing sharply when investors question how long AI spending will last. Export limits on chip sales to China, rising competition from custom chips built by its own customers, and dependence on a small group of very large buyers remain factors to monitor.
CrowdStrike (CRWD) – A Leader in Cloud-Based Security
CrowdStrike sells cybersecurity software that protects laptops, servers, cloud workloads, and user identities from attacks. Customers buy the service by subscription, which gives the company recurring revenue. Over time, CrowdStrike has added more products to the same platform, so existing customers can buy more without installing new systems. In our view, the steady rise in cyberattacks makes security one of the last budgets companies cut.
Consensus on CrowdStrike reads strong buy, though a number of firms rate it neutral. Citigroup's Fatima Boolani kept a Buy rating and raised her price target on October 15.
Risks: The stock trades at a high valuation, which leaves little room for disappointing results. Competition from Microsoft, Palo Alto Networks, and other security vendors, along with pricing pressure from bundled deals, remains a factor to monitor.
Eli Lilly (LLY) – Riding Demand for Obesity and Diabetes Drugs
Eli Lilly makes some of the most widely used drugs for type 2 diabetes and weight loss. Demand for this class of medicines has outpaced supply at times, and the company has spent heavily on new manufacturing plants. Lilly also has a pipeline that includes newer obesity treatments, including pill forms, as well as drugs for Alzheimer's disease and cancer. In our view, Lilly's lead in obesity treatment gives it one of the strongest growth outlooks among large drug makers.
Consensus on Eli Lilly reads strong buy, with nearly all covering firms rating the stock bullish.
Risks: Drug pricing pressure from the U.S. government, insurance coverage limits for weight-loss drugs, and competition from Novo Nordisk and new entrants remain factors to monitor. Trial setbacks in the pipeline could also weigh on the stock.
GE Vernova (GEV) – Building Out the Power Grid
GE Vernova makes gas turbines, grid equipment, and wind turbines. Utilities and data center developers need more electricity, and gas turbines and grid upgrades are central to adding power quickly. That demand has helped the company build a large order backlog. In our view, rising power use from data centers, factories, and electrification gives GE Vernova years of potential demand.
Consensus on GE Vernova reads strong buy, with most covering firms bullish. Guggenheim's Joseph Osha reiterated his Buy rating on October 13.
Risks: The wind business has struggled with losses and project problems. Supply-chain limits, delays in utility spending, and a valuation that already prices in strong growth remain factors to monitor.
Amazon (AMZN) – E-Commerce Scale Plus a Cloud Engine
Amazon runs the largest online store in the U.S. and the largest cloud computing business in the world, Amazon Web Services. The cloud unit rents computing power and AI tools to businesses, while advertising has become a fast-growing source of profit across the retail side. Amazon is also building its own AI chips to lower costs. In our view, the cloud and advertising businesses give Amazon several ways to grow even if online shopping slows.
Consensus on Amazon reads strong buy, with nearly every covering firm bullish.
Risks: Heavy spending on data centers could weigh on cash flow if AI demand cools. Competition from Microsoft and Google in the cloud, antitrust scrutiny, and the health of consumer spending remain factors to monitor.
Found this helpful? Share it with others.